Company Filing History:
Years Active: 1993-1998
Title: **Ellis F Unger: Innovator in Cardiovascular Therapeutics**
Introduction
Ellis F Unger is a notable inventor based in Silver Spring, MD, USA, recognized for his contributions to innovations in cardiovascular treatments. With two granted patents, he has made significant strides in the field of medical science, particularly focusing on methods that enhance blood vessel functionality and inhibit unwanted cell proliferation.
Latest Patents
Unger’s latest patents include groundbreaking methodologies aimed at improving heart health. The first patent, titled "Inhibition of cell proliferation using antisense oligonucleotides," provides a method to prevent restenosis, or the re-narrowing of blood vessels, following mechanical treatments. This method employs antisense oligonucleotides that specifically target and inhibit the expression of cellular division cycle genes, notably c-myc, PCNA, and cyclin B.sub.1. By doing so, it effectively reduces the proliferation of smooth muscle cells in the affected blood vessel.
His second patent, "Method to foster myocardial blood vessel growth and improve blood flow," outlines a technique that promotes the growth of cardiac blood vessels in damaged hearts. This innovative approach not only facilitates better circulation in areas of the heart that need it most but also reduces the risk of undesirable vascularization in other parts of the body.
Career Highlights
Ellis F Unger has had an impactful career characterized by his focus on advancing cardiovascular health solutions through research and practical applications. He is associated with the Department of Health in the United States of America, where he collaborates with fellow researchers to develop and refine medical technologies. His work is crucial in addressing significant health challenges related to heart disease and vascular health.
Collaborations
Throughout his career, Unger has collaborated with esteemed colleagues, including Stephen E Epstein and Edith H Speir. These collaborations have played a vital role in nurturing innovations that can lead to better medical outcomes for patients suffering from cardiovascular conditions.
Conclusion
Ellis F Unger's dedication to enhancing cardiovascular health through innovative solutions marks him as a significant figure in medical research. His patents reflect a commitment to improving patient outcomes by tackling complex issues surrounding blood vessel health. With a strong background and ongoing collaborations, he continues to contribute meaningfully to the field of cardiovascular therapeutics.